Beta-Sitosterol Plus
Natural health product licensed in Canada
- Licence holder
- Phytogenics Inc.
- NPN or DIN-HM
- 80069626
- Status
- Active licence
- Licence date
- 24 May 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Styphnolobium japonicum - Bourgeon floral | 100 milligramme | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 90 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 120 milligramme | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 50 % beta-Sitosterol | Not specified | Not calculated |
| 4',5,7-Trihydroxyisoflavone Source : Glycine max - Graine | 17 mg ÉAI | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
An antioxidant. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you currently have or previously had breast cancer and/or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have a history of hormonal or gynaecological disease, including ovarian cancer, endometriosis, and/or uterine fibroids. Consult a health care practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). Consult a health care practitioner prior to use if you are taking hormone replacement therapy (HRT), including thyroid hormone replacement therapy. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort and/or tenderness, or if you experience a recurrence of menstruation and/or uterine spotting. Consult a health care practitioner prior to use if you have a history of hormonal disease, including prostate cancer. Do not use if you currently have or previously had prostate cancer. Discontinue use and consult a health care practitioner if you experience breast swelling, erectile dysfunction and/or changes in mood, libido or hair growth. If you are attempting to conceive, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80069626
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.